| Part B: Supplementary Information Sheet (SIS) |
|
FR Recognition List Number
|
065
|
Date of Entry 12/22/2025
|
|
FR Recognition Number
|
13-153
|
| Standard | |
AAMI CR515:2025 Cybersecurity Consideration Unique to Machine-Learning Enabled Medical Devices |
|
Scope/Abstract| This consensus report specifically addresses the unique cybersecurity threats associated with developing and deploying machine learning-enabled medical device software, as distinct from the broader cybersecurity risks applicable to all medical device life cycle phases. This includes potential cybersecurity threats that can arise from or during data collection, product design, product deployment, product use, and maintenance. |
|
| Extent of Recognition
|
Rationale for Recognition
This standard is relevant to medical devices and is recognized on its scientific and technical merit and/or because it supports existing regulatory policies.
NOTE: Conformance to this standard may not satisfy all the cybersecurity requirements outlined in Section 524B of FD&C Act or the recommendations in the (1) listed below (Relevant FDA Guidance). Manufacturers should consider the information contained within these resources in their assessment of cybersecurity for their device. |
|
Relevant FDA Guidance and/or Supportive Publications*
1. Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions, Guidance for Industry and Food and Drug Administration Staff, issued February 2026.
2. Postmarket Management of Cybersecurity in Medical Devices, Guidance for Industry and Food and Drug Administration Staff, issued December 2016.
3. Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence, Enabled Device Software Functions, Guidance for Industry and Food and Drug Administration Staff, issued August 2025.
Appropriate Use of Voluntary Consensus Standards in Premarket Submissions for Medical Devices - Guidance for Industry and Food and Drug Administration Staff, issued September 2018. |
|
| FDA Technical Contact
|
| Standards Development Organization
|
| FDA Specialty Task Group (STG)
|
| *These are provided as examples and others may be applicable. |